Compumedics

Compumedics is an Australian neurotechnology company headquartered in Melbourne that designs and manufactures diagnostic and monitoring systems for neurological applications. The company specializes in sleep diagnostic equipment, EEG (electroencephalography) systems, and transcranial Doppler ultrasound devices used in both clinical and research settings. Their product portfolio includes the Grael and Somté families, which represent industry-leading platforms for comprehensive neurological assessment and monitoring. These systems integrate multiple measurement modalities to provide clinicians and researchers with detailed insights into brain activity and cerebrovascular function.

As a publicly listed company on the Australian Securities Exchange (ASX: CMP), Compumedics has established itself as a significant player in the neurodiagnostics market with global reach. The company's Grael and Somté product families are widely deployed across hospital sleep laboratories and research institutions worldwide, demonstrating strong market adoption and clinical validation. Through decades of development and refinement, Compumedics has built a substantial installed base and reputation for reliability, making it a trusted partner for institutions requiring sophisticated neurological monitoring capabilities.

Compumedics plays an important role in the neurotech industry by providing essential diagnostic infrastructure for sleep medicine, neurology, and brain research. The company's systems enable early detection and management of neurological disorders such as sleep apnea, epilepsy, and cerebrovascular disease, contributing to improved patient outcomes and clinical understanding. By combining rigorous engineering with clinical expertise, Compumedics helps advance the field of neurodiagnostics while maintaining accessibility through proven, standardized platforms that support both routine clinical care and cutting-edge research applications.